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Abstract
Introduction: The purpose of this meta-analysis was to examine the efficacy of exercise to reduce depressive symptoms
among cancer survivors. In addition, we examined the extent to which exercise dose and clinical characteristics of cancer
survivors influence the relationship between exercise and reductions in depressive symptoms.
Methods: We conducted a systematic search identifying randomized controlled trials of exercise interventions among adult
cancer survivors, examining depressive symptoms as an outcome. We calculated effect sizes for each study and performed
weighted multiple regression moderator analysis.
Results: We identified 40 exercise interventions including 2,929 cancer survivors. Diverse groups of cancer survivors were
examined in seven exercise interventions; breast cancer survivors were examined in 26; prostate cancer, leukemia, and
lymphoma were examined in two; and colorectal cancer in one. Cancer survivors who completed an exercise intervention
reduced depression more than controls, d+=20.13 (95% CI: 20.26, 20.01). Increases in weekly volume of aerobic exercise
reduced depressive symptoms in dose-response fashion (b=20.24, p=0.03), a pattern evident only in higher quality trials.
Exercise reduced depressive symptoms most when exercise sessions were supervised (b=20.26, p=0.01) and when cancer
survivors were between 47–62 yr (b=0.27, p=0.01).
Conclusion: Exercise training provides a small overall reduction in depressive symptoms among cancer survivors but one
that increased in dose-response fashion with weekly volume of aerobic exercise in high quality trials. Depressive symptoms
were reduced to the greatest degree among breast cancer survivors, among cancer survivors aged between 47–62 yr, or
when exercise sessions were supervised.
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Introduction
There are over 12 million cancer survivors in the US [1]. Nearly
100% of all cancer survivors experience psychological and physical
symptoms and side effects related to cancer or cancer treatment [2].
Cancer survivors may experience fear of death, disease relapse, and
body image changes [3] that can contribute to the depressive
symptoms experienced by up to 60% of cancer survivors [4]
compared to 7% of the general US population [5]. Depression is
associatedwithchemotherapynoncompliance[6,7]andreduced5 yr
survival rates [8,9]. Therefore, appropriate management of depres-
sive symptoms among cancer survivors is of clinical importance.
Exercise is an effective non-pharmacological therapy to reduce
depressive symptoms among those living with depression [10], with a
moderate standardized mean reduction when compared to thosewho
do not exercise. Exercise provides similar or larger reductions in
depressive symptoms in an array of clinical populations including
those living with chronic obstructive pulmonary disease [11], human
immunodeficiency virus [12], and coronary artery disease [13].
Accumulating evidence suggests exercise training after diagnosis
of cancer may improve functional capacity, muscular strength,
quality of life, and reduce cancer-related fatigue [14–16], but the
efficacy of exercise to reduce depressive symptoms is inconsistent
[2]. Some studies have demonstrated moderate to large reductions
in depressive symptoms as the result of exercise [17,18], whereas
others observe no such reductions [19,20]. Although a previous
meta-analysis quantified the heterogeneity of exercise interven-
tions to reduce depressive symptoms among cancer survivors and
reported a moderate to large amount of heterogeneity (I
2=55%–
76%), it did not examine moderator variables that could explain
the variability in results [16].
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Brown      Therefore, this meta-analysis examined the efficacy of exercise
to reduce depressive symptoms among cancer survivors, confirm-
ing a previous meta-analysis [16], and attempted to identify
exercise prescription and clinical factors associated with the
greatest reductions in depressive symptoms. Identification of
characteristics moderating the magnitude of reduction in depres-
sive symptoms may aid clinicians in prescribing tailored exercise
interventions to manage depressive symptoms among cancer
survivors.
Methods
Inclusion Criteria
Studies were identified on a priori criteria that included: (1) a
randomized controlled design comparing an exercise intervention
with a control group (i.e., no exercise program prescribed and
instructions to maintain current activity levels or no exercise
related information); (2) report of depression outcomes; and (3)
adults diagnosed with any type of cancer, regardless of stage of
diagnosis or type or stage of treatment. Exercise interventions
occurring in any setting, with or without supervision, were eligible.
Systematic Search
The databases PubMed, PsycINFO, CINAHL Plus, SPORTS-
discus, OregonPDF in Health and Performance, and ProQuest
Theses and Dissertations were searched through Nov 18, 2010.
We searched all databases using a Boolean search strategy [i.e.,
(cancer OR neoplas* OR tumor OR chemo* OR radiat* OR
malign* OR carciniom*) AND (depress* OR anxiety OR anxious
OR worried OR scared OR nervous OR cognitive OR
biofeedback OR relaxation OR social support OR mind-body)
AND (exercise OR physical activity OR aerobic OR cardiovas-
cular OR resistance OR strength OR muscular OR flexibility OR
walking OR program OR interval OR sport OR fitness OR
performance OR movement OR stretching OR tai chi OR yoga
OR dance OR body OR composition)]. Journals focusing on
cancer survivorship (Journal of Clinical Oncology, Breast Cancer Research
and Treatment, Journal of Cancer Survivorship, Oncology Nursing Forum),
and the reference lists of included studies were also searched for
additional reports.
Coding and Reliability
We estimated the intensity of exercise using the compendium of
metabolic equivalent units (METs), where 1 MET represents
sitting quietly (3.5 ml O2?kg
-1?min
-1) and ,3 METs, 3 to ,6
METs, and $6 METs represent low, moderate, and vigorous
intensity exercise, respectively [21]. We calculated the weekly
volume of aerobic exercise as the product of minutes of daily
exercise and frequency of exercise sessions per week (min?wk
21).
We used the Physiotherapy Evidence Database scale (PEDro) to
gauge methodological quality of the trials in terms of internal
validity and statistical reporting [22]. Four independent, trained
raters extracted information related to the study with high inter-
rater reliability, mean Cohen’s k=0.90, for categorical variables,
and mean intra-class correlation r=0.94 for continuous variables.
Study Outcome and Effect Size Calculation
The studies assessed depressive symptoms among cancer
survivors as a continuous outcome variable assessed as a
component of a comprehensive psychological questionnaire with
a depression subscale [23] or a questionnaire solely assessing
depression levels [24–27]. To assess baseline levels of depressive
symptoms on a common metric across depression questionnaires,
we used a 0–100 scale, where ‘0’ implies absolutely no depressive
symptoms, and ‘100’ implies the highest level of symptoms possible
on a given scale. We used the standardized mean difference effect
size (d) to quantify the difference in depression from baseline to
follow-up between the exercise and control groups, correcting for
small sample size bias [28,29]. The effect size d denotes the
difference between the mean depression values of the control and
exercise groups, divided by the pooled standard deviation [30]; the
sign of d values was set to be negative when the exercise group
reduced depression more than the control group. The standard-
ized d value can be interpreted as 20.20, 20.50, and 20.80,
represent small, medium, and large reductions in depressive
symptoms, respectively [31]. When trials included more than one
exercise group (e.g., aerobic exercise and resistance exercise), we
calculated multiple effect sizes. Sensitivity analysis examined the
influence of a single study on the overall mean effect size of all
trials by iteratively removing a single study and then re-estimating
the overall mean effect with 95% confidence intervals [32]. We
present overall mean effect sizes (d+) as both, fixed- and random-
effects estimates.
We used Stata 11.1 (StataCorp, College Station, TX) with
macros developed for meta-analysis [33] to perform all statistical
analyses. Begg’s test [34] (z=21.67, p=0.10), Egger’s test [35]
(t=20.12, p=0.90), and the trim-and-fill method [36] identified
no asymmetries in the effect size distribution suggestive of
publication bias. Potential heterogeneity or between-study vari-
ance was calculated as Q and I
2 (and 95% CI) [37,38]. The Q
statistic follows an approximate x
2 distribution with k-1 degrees of
freedom, where k is the number of studies included in the meta-
analysis [38]. The Q statistic can be standardized to I
2 with values
ranging from 0% (homogeneity) to 100% (heterogeneity). To
explain variance of depressive symptom reduction—the relation
between study-level characteristics and the magnitude of the
depression reduction effect size (d+)—a modified, weighted least
squares regression was used with weights equal to the inverse
variance of each exercise intervention effect size (viz., fixed-effects
meta-regression). The underlying assumptions of meta-regression
are similar to that of ordinary least-squares regression, including
independence of errors, homoscedasticity of variance, and
normally distributed variables [28,33,39,40]. Statistically signifi-
cant bivariate regression analyses were integrated into a multiple-
moderator fixed effects regression to determine which variables
could explain unique between study variance. To reduce multi-
collinearity in multiple meta-regression models, all continuous
variables were zero centered based on their means; categorical
variables were contrast coded (21/+1). Beta-values (b) appear in
standardized form in order to quantify the amount of variability in
ds associated with each moderator of interest. All meta-regression
model estimated effect sizes are depicted using the moving
constant technique, entering multiple predictor variables simulta-
neously [41]. Two-sided statistical significance was p,0.05.
Results
Methodological Characteristics
Qualifying for inclusion in the meta-analysis were 37 relevant
randomized controlled exercise interventions [17–20,42–74]
(N=2,929) with a total of 40 comparisons (k=40) of exercise
versus control conditions (Figure 1). Thirty-four studies provided
one effect size, and three provided two effect sizes [20,44,52].
Exercise interventions were published in 200664.2 (range: 1994–
2010) with most studies (70%) conducted in North America. The
mean PEDro score of the exercise interventions was 7.061.0
suggesting relatively high methodological quality [22]. A minority
of studies (20%) reported that they implemented at least one
Exercise and Depression: Meta-Analysis
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using the Center for Epidemiologic Studies-Depression question-
naire (40%) [25], Profile of Mood States (23%) [23], the Beck
Depression Inventory (18%) [24], Hospital Anxiety and Depres-
sion Scale (12%) [26], or Symptom Assessment Scale (7%) [27].
Cancer Survivor Characteristics
Cancer survivors participating in the exercise trials averaged
51.366.5 yr (range: 39–70). The majority of cancer survivors
participating in the exercise interventions were white, non-
Hispanic (n=2,255; 77%), and women (n=2,548; 87%) with a
time since cancer diagnosis of 25.3619.6 months (range: 2.8–
73.0). Exercise interventions were more common during curative
therapy with 29 of the 40 exercise interventions (73%) occurring
during treatment (i.e., chemotherapy or radiation treatment).
Trials most often examined breast cancer survivors (k=24)
[17,20,48–69]. Two trials each focused on prostate cancer
[19,70], leukemia [72,73], and lymphoma [18,74] survivors, and
only one trial examined colorectal cancer survivors [71]. The
remaining 6 trials examined survivors with diverse types of cancer
diagnoses [42–47]. At baseline, the standardized metric of
depressive symptoms was 34.2626.9 and ranged from 3.49 to
81.5.
Exercise Intervention Characteristics
The mean length of the exercise interventions was
13.2611.7 wk with an average of 3.062.5 sessions per week
lasting 49.1627.1 min?session
21. Average weekly volume of all
exercise was 129.4664.9 min?wk
21. Exercise modalities included
walking (k=16; 40%), stationary cycling (k=5; 13%), weight
machines (k=2; 5%), resistance bands (k=3; 8%), and yoga (k=8;
20%). In addition, flexibility exercises were prescribed in 50% of
the exercise interventions. The absolute intensity of exercise was
3.961.3 METs indicating they were of low (i.e., ,3 METs) to
moderate (i.e., $3t o,6 METs) intensity. A majority of exercise
interventions (60%) was supervised. Table S1 summarizes
methodological characteristics of the included trials.
The Influence of Exercise on Depressive Symptoms
Exercise provided a small overall reduction in depressive
symptoms compared to standard care among all types of cancer
[d+=20.13 (95% CI: 20.26, 20.01)]. Subgroup analysis by
cancer type revealed significant reductions in depressive symptoms
among breast cancer survivors [d+=20.17 (95% CI: 20.32,
20.02)], but no significant difference in depressive symptoms
among prostate, leukemia, lymphoma, and colorectal cancer
survivors (Table 2). Figure 2 depicts the fixed-effects mean
reduction in depressive symptoms, stratified by type of cancer.
Collectively, the 40 effect sizes lacked homogeneity [I
2=55%
(95% CI: 35–68), p,0.001], as did the analysis when restricted to
breast cancer survivors [I
2=59% (95% CI: 37–73), p,0.001;
Table 2].
Moderators of the Influence of Exercise on Depressive
Symptoms
Three moderators explained unique variance relating to the
efficacy of exercise to reduce depressive symptoms when entered in
a multiple meta-analysis regression model. Weekly volume of
aerobic exercise reduced depression in dose-response fashion
(b=20.24, p=0.03), a pattern that was only evident in higher
quality trials. Exercise reduced depressive symptoms most when
exercise sessions were supervised (b=20.26, p=0.01) and cancer
survivors were between 47–62 yr [(b=0.27, p=0.01); Table 3].
These three moderators together explained 35% of the variance in
depression reduction resulting from exercise; yet, variability
beyond that expected by sampling error alone remained
unexplained.
In our bivariate analyses (Table S2), three other features related
to the magnitude of exercise-induced reduction of depressive
symptoms: explicit use of theory in intervention development, the
percentage of non-Hispanic Whites in the sample, and time since
cancer diagnosis. Interventions were more successful in reducing
depressive symptoms when they used psychological theory,
sampled greater percentages of non-Hispanic Whites, and were
more proximal to the date of cancer diagnosis. Still, none of these
moderators explained significant variability in combined moder-
ator analysis, suggesting that their influence is explained by the
variables in the combined moderator model (viz., supervision,
volume of exercise, methodological quality, and age; see Table 3).
Standardized baseline depressive symptom scores were not
associated with depressive symptom improvements resulting from
exercise (p=0.71).
Discussion
This review found that exercise provided a small overall
reduction in depressive symptoms among cancer survivors,
d+=20.13 (95% CI: 20.26, 20.01), but the amount of change
varied widely across studies. Our analysis revealed exercise
reduced depressive symptoms among breast cancer survivors,
d+=20.17 (95% CI: 20.32, 20.02), a pattern that confirms
previous reports in the literature [2,75,76]. We observed non-
significant exercise-related reductions in depressive symptoms
among prostate, colorectal, leukemia, and lymphoma survivors,
but the lack of statistical significance among these types may be
due in part to the small numbers of included studies and
subsequent lowered statistical power to detect effects (Table 2).
Of note, in bivariate analyses a model related to type of cancer
revealed no difference (results not shown), suggesting that the
depression-reducing effects of exercise may generalize to other
types of cancer.
Figure 1. Flow diagram of exercise intervention identification
and selection.
doi:10.1371/journal.pone.0030955.g001
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k(%) where noted).
Descriptive Statistic All Cancer Breast Prostate Leukemia Lymphoma
Study Characteristics
Number of studies, k 40
a (100%) 26
b (65%) 2 (5%) 2 (5%) 2 (5%)
Year of study 200664.2 200663.9 200862.1 200860.7 200663.5
Published in journal, k 34 (85%) 21 (81%) 2 (100%) 2 (100%) 2 (100%)
PEDro quality 7.061.0 6.761.1 7.060.0 7.560.7 7.560.7
Subject Characteristics
Total n 2929 (100%) 1796 (61%) 121 (4%) 66 (2%) 161 (6%)
Gender, n of women 2548 (87%) 1796 (100%) 121 (0%) 22 (33%) 61 (38%)
Ethnicity, n (% total n)
White, non-Hispanic 2255 (77%) 1437 (80%) – – –
African-American 498 (17%) 296 (16%) – – –
Hispanic 88 (3%) 54 (3%) – – –
Asian 59 (2%) 18 (1%) – – –
Age, yr 51.366.5 50.964.7 68.561.2 45.268.6 52.161.5
Stage of treatment, k
Currently treated 29 (73%) 17 (65%) 2 (100%) 2 (100%) 2 (100%)
Previously treated 11 (27%) 9 (35%) – – –
Time since diagnosis, mo 25.3619.6 26.9621.3 – – 29.268.0
Exercise Intervention Characteristics
Intervention length, wk 13.2611.7 15.5614.2 12.065.6 4.061.4 9.563.5
Length, minNsession
21 49.1627.1 54.7627.5 65.0635.4 36.0633.9 61.2640.6
Frequency, sessionNwk
21 3.062.5 2.861.3 2.061.4 5.060.0 2.061.4
Exercise volume, minNwk
21 123.9652.2 135.2625.1 105.0621.2 180.06169.7 97.560.0
Aerobic intensity, MET 4.861.1 4.760.9 4.460.8 5.462.3 7.060.0
Strength intensity, MET 2.960.5 2.960.6 3.060.0 3.060.0 2.560.0
Neuromuscular, MET 2.560.0 2.560.0 – – 2.560.0
Flexibility, k
Included 20 (50%) 13 (50%) 2 (100%) 1 (50%) 1 (50%)
Excluded 20 (50%) 13 (50%) – 1 (50%) 1 (50%)
Supervision, k
Supervised 24 (60%) 19 (73%) 2 (100%) 2 (100%) 2 (100%)
Unsupervised 16 (40%) 7 (27%) – – –
Use of theory, k
None 32 (80%) 21 (81%) 2 (100%) 2 (100%) 1 (50%)
Psychological 8 (20%) 5 (19%) – – 1 (50%)
Depression Scale used, k
CES-D 16 (40%) 9 (35%) 1 (50%) – 2 (100%)
POMS 9 (23%) 7 (27%) – 1 (50%) –
BDI 7 (18%) 6 (23%) 1 (50%) – –
HADS 5 (13%) 2 (8%) – 1 (50%) –
SAS 3 (8%) 2 (8%) – – –
NOTE: Percentages may not sum to 100% due to rounding error.
CES-D, Center for Epidemiologic Studies Depression scale; POMS, Profile Of Mood States; BDI, Beck Depression Inventory; HADS, Hospital Anxiety and Depression Scale;
SAS, Symptom Assessment Scale.
k, number of studies included.
MET, metabolic equivalent, 1MET=3.5 ml O2?kg?min
21.
a37 studies provided 40 total effect size estimates.
b24 studies provided 26 total effect size estimates.
doi:10.1371/journal.pone.0030955.t001
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depression measures to indicate whether one may suffer from
depression. The questionnaires used to assess depression varied
with respect to content of questions, scoring, and cut-points used
for clinical judgment, making the comparability of depression at
baseline between trials difficult, and making the clinical general-
izability of the current results more difficult. Therefore, we chose
to focus our discussion on the standardized mean difference effect
size, and the statistical interpretation of the association between
exercise and depressive symptoms, rather than clinical signifi-
cance.
We attempted to elucidate the exercise dose and clinical
characteristics moderating the overall reduction of depressive
symptoms among cancer survivors. To date, one meta-analysis has
Figure 2. Forest plot of depressive symptom reduction by cancer group.
doi:10.1371/journal.pone.0030955.g002
Table 2. Weighted mean effect of exercise modulating depressive symptoms by type of cancer.
d+ (95% CI) Consistency of ds
Type of Cancer k Fixed Effects Random Effects Q
c I
2 (95% CI) P
c
All Cancer 40
a 20.13 (20.21, 20.06) 20.13 (20.26, 20.01) 86.13 55% (35, 68) ,0.001
Breast 26
b 20.19 (20.28, 20.09) 20.17 (20.32, 20.02) 60.79 59% (37, 73) ,0.001
Prostate 2 20.20 (20.66, 0.25) 20.20 (20.82, 0.40) 0.00 0% (0, 100) 0.948
Leukemia 2 20.22 (20.73, 0.30) 20.24 (20.89, 0.40) 0.94 0% (0, 100) 0.332
Lymphoma 2 20.35 (20.67, 20.03) 20.30 (20.89, 0.29) 0.64 0% (0, 100) 0.424
Colorectal 1 20.08 (20.52, 0.35) – – – –
NOTE: Weighted mean effect size values (d+) are negative when the exercise intervention was successful in reducing depression compare to standard care.
k, number of studies.
a37 studies provided 40 total effect size estimates.
b24 studies provided 26 total effect size estimates.
cSignificance implies rejection of the hypothesis of homogeneity and the inference of heterogeneity.
doi:10.1371/journal.pone.0030955.t002
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depressive symptoms among cancer survivors [76]. This previous
meta-analysis examined individual moderators of depressive
symptoms [76], whereas our meta-analysis examined multiple
moderators simultaneously. Aerobic exercise reduced depressive
symptoms in dose-response fashion such that as weekly minutes of
aerobic exercise increased, so did reductions in depressive
symptoms, a finding observed only in higher quality trials
(Table 3). In higher quality trials, the amount of depressive
symptom reduction reached large magnitude for those with
3 hours per week of aerobic exercise.
Since the overall mean reduction in depressive symptoms was
small in magnitude, it is plausible that only the methodologically
rigorous studies were able to detect such an effect in depressive
symptom reduction. These trends are consistent with evidence
suggesting exercise reduces depressive symptoms in dose-response
fashion among populations with depression [77] and among
cancer survivors [76]. Consistent with our findings, the American
College of Sports Medicine consensus statement on exercise and
cancer survivorship suggests all cancer survivors should strive to
achieve a large volume of aerobic exercise of $150 min?wk
21 to
maximize the health benefits [2]. Moreover, accumulating large
volumes of aerobic exercise should be progressive, increasing
duration and frequency of exercise over weeks or months of
exercise training as the course of the disease process allow and
functional capacity improves [2,78,79].
Our results showed that cancer survivors engaging in supervised
exercise experienced less depressive symptoms than those who
engaged in unsupervised exercise. Similar patterns have appeared
in prior meta-analyses addressing the effects of exercise on quality
of life [14], fatigue reduction [80], and depressive symptoms [76]
among cancer survivors. Moreover, Spence et al., and Whitehead
et al., found breast and colon cancer survivors prefer supervised
exercise training over unsupervised exercise [81,82].
We found exercise reduced depressive symptoms more among
cancer survivors between 47–62 yr than those younger than 47 yr
and older than 62 yr. Because previous studies reported higher
levels of psychosocial stress, including depressive symptoms,
among younger cancer survivors [83,84], we hypothesized it
would be younger cancer survivors who would experience the
greatest reductions in depressive symptoms attributable to
exercise. It is unclear why cancer survivors younger than 47 yr
did not experience significant exercise-induced reductions in
depressive symptoms, on average (Table 3). One possibility is that
the average weekly aerobic exercise volume performed
(,130 min?wk
21) was not a large enough dose of exercise to
reduce depressive symptoms among cancer survivors younger than
47 yr. The fact that no significant reduction in depressive
symptoms among cancer survivors older than 62 yr appeared
may be due in part to a floor effect [10]. That is, older cancer
survivors report less depressive symptoms at baseline [85], and
may show smaller exercise-induced improvements in depressive
symptoms compared to those who are middle-aged.
The release of monoamine neurotransmitters (i.e., serotonin,
dopamine, and norepinephrine) and endorphins during aerobic
exercise has provided preliminary mechanistic support for the use
of aerobic exercise to reduce and manage depressive symptoms
[86,87] and avoids common side-effects associated with anti-
Table 3. Characteristics related to depressive symptoms change for all cancer survivors.
Study dimension and level
a Adjusted
b d+ (95% CI) b
c P
Accumulated weekly volume of aerobic
exercise, minNwk
16PEDro methodological
score (Continuous )
d
PEDro=10 (higher quality) 90 min?wk
21 20.07 (20.42, 0.27) 20.24
e 0.03
120 min?wk
21 20.28 (20.54, 20.02)
150 min?wk
21 20.49 (20.77, 20.23)
180 min?wk
21 20.71 (21.09, 20.33)
PEDro=5 (lower quality) 90 min?wk
21 20.29 (20.54, 0.04)
120 min?wk
21 20.19 (20.40, 0.02)
150 min?wk
21 20.09 (20.34, 0.14)
180 min?wk
21 0.00 (20.34, 0.34)
Supervision of exercise Unsupervised 20.13 (20.23, 20.04) 20.26 0.01
Supervised 20.36 (20.55, 20.18)
Age,
f y (Continuous -Quadratic)4 0 0 . 1 6 ( 20.08, 0.41) 0.27 0.01
50 20.20 (20.30, 20.10)
60 20.25 (20.42, 20.08)
70 0.01 (20.47, 0.56)
NOTE: Weighted mean effect size values (d+) are negative when the exercise intervention reduced depression compared to the control group.
aLevels represent values of interest of each moderator; in these models, continuous variables were represented in their continuous form; the estimates adjust for the
other moderators in the model.
bd+ and their 95% CI estimates statistically adjust for the presence of the rest of the moderators in the fixed-effects model, including weekly minutes of exercise6PEDro
interaction and their independent linear terms, supervision of exercise, quadratic and linear trends for age, held constant at their means except for the study dimension
in question.
cb values are standardized.
dThis is a continuous6continuous interaction. We chose to report PEDro scores of 5 and 10 to highlight the variability along the continuous distribution of PEDro scores,
those of very high quality (i.e., 10) versus those of low quality (i.e., 5).
eb for interaction. Independent b: weekly aerobic volume, b=20.09; PEDro methodological score, b=20.28.
fContinuous quadratic trend including linear component.
doi:10.1371/journal.pone.0030955.t003
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associated with improved neurological function; increasing
neurotropic factors in the brain and improving mood [90].
Nonetheless, these hypotheses are limited in explaining the
complex physiological and psychosocial etiologies of depressive
symptoms [87]. Studies in the current meta-analysis rarely
included physiological measures, impeding clear tests of such
hypotheses. Continued research is necessary to examine mecha-
nisms underpinning the reduction of depressive symptoms in
response to exercise.
Limitations
The major limitation of this meta-analysis is that depressive
symptoms were a secondary outcome in almost all exercise
interventions. As such, cancer survivors in the exercise trials that
we meta-analyzed were not recruited based on depression levels;
moreover, they may have exhibited few depressive symptoms at
baseline. Nonetheless, our analysis suggests exercise is efficacious
to improve depressive symptoms among cancer survivors. Our
analysis may underestimate the efficacy of exercise to reduce
depressive symptoms among cancer survivors with higher levels of
depression or those with a diagnosis of depression. Furthermore,
our analysis and interpretation of our findings have focused on the
statistical associations, not the clinical implications of exercise and
the experience of depressive symptoms.
Despite our intention to include all types of cancer of any race,
26 of the 40 effect sizes (65%) targeted white, non-Hispanic, breast
cancer survivors exclusively, which has been a limitation of
previous meta-analyses examining a variety of health-related
outcomes among cancer survivors [14–16]. Additionally, the
number of exercise interventions among breast cancer survivors
limits the generalizability of our findings to other types of cancer,
even though there was no significant difference in reduction of
depressive symptoms attributable to type of cancer. These
limitations should provide an impetus for researchers to continue
investigating the effects of exercise among other ethnic groups and
underrepresented cancer types.
Despite an overall rating of high methodological quality
(7.061.0 of 11), we noted some consistent methodological
weaknesses throughout the literature, such as inclusion of small
sample sizes, inconsistent criteria with respect to study entry
eligibility and baseline depressive symptoms levels, poor reporting
of adverse events, and failure to follow intent-to-treat analytic
strategies. Indeed, the dose-response pattern of exercise to the
reduction of depression symptoms materialized most clearly only
in the studies with the highest methodological quality.
Conclusion
In closing, we confirmed that exercise provides a small overall
reduction in depressive symptoms among cancer survivors.
Depressive symptom reduction occurred in dose-response fashion
with weekly volume of aerobic exercise, with high-quality trials
documenting large changes for cancer survivors accruing larger
weekly volumes of aerobic exercise. Larger reductions in
depressive symptoms also occurred with supervised exercise, and
among cancer survivors 47–62 yr. Cancer survivors should strive
to avoid physical inactivity; discuss the safety and feasibility of
exercising with their medical care provider to optimize depressive
symptoms management; and eventually aim to achieve larger
weekly volumes of aerobic exercise if possible, complimented with
resistance training twice-weekly, and flexibility activity on days of
non-exercise [2]. Furthermore, clinicians now have evidence to
advocate the potential benefit of aerobic exercise as a modality to
manage depressive symptoms among cancer survivors.
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